Using research to inform and change primary care Professor James Dunbar Greater Green Triangle UDRH

Slides:



Advertisements
Similar presentations
PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.
Advertisements

National Service Frameworks Dr Stephen Newell February 2002.
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
JNC 8 Guidelines….
Salford Primary Care Trust – your leader for health IN Salford Salford Primary Care Trust 5-year Strategic Plan 2009 – 2014 Briefing to the Salford Strategic.
Modelling the potential economic impact of investment in Public Health Professor Malcolm Whitfield Director of The Centre for Health & Social Care Research.
CVD risk estimation and prevention: An overview of SIGN 97.
Level Health Equally Well Key findings from a literature review informing collaborative efforts to improve the physical health outcomes of people with.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
1 Integration of Noncommunicable Diseases into PHC in low-resource settings Lessons learned Dr Shanthi Mendis Chronic Disease Prevention and Management.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
David R MacLean MD Professor & Director Institute for Health Research & Education Simon Fraser University A Case for Integrated Chronic Disease Prevention.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Promoting Excellence in Cardiovascular Disease Prevention and Rehabilitation The BACPR Standards and Core Components for Cardiovascular Prevention and.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Social Aspects of Diseases. Dr. Mostafa Arafa Associate Prof. of Family and Community medicine Faculty of medicine, medical sciences King Khaled University,
CVD Prevention in Primary Care CVD Guidelines Symposium Wednesday 3 rd Novemeber 2010 Dr John Cox FRCPI FRCGP.
A raised thyroid stimulating hormone result is associated with an increased rate of cardiovascular events and would benefit from treatment Gibbons V, Conaglen.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
CVD preventive interventions WORKSHOP Jurate Klumbiene Kaunas University of Medicine, Kaunas, Lithuania.
What is a National Health Priority Area?  National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national.
The National Health Priority Areas
Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.
PACIFIC NURSING SMOKEFREE PROJECT VISION: To enable equitable health outcomes for colleagues and Pacific peoples smoking in our population.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Improving the Quality of Physical Health Checks
Improving the Quality of Physical Health Checks Kate Dale, Mental/Physical Health Lead BDCT.
AHPs an integral part of the public health workforce Linda Hindle, Allied Health Professions Lead.
Developing Cardiac Rehabilitation in Vietnam Dr Juliette Hussey School of Medicine Trinity College Dublin Ireland.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Simon Belderbos Consultant Psychiatrist
NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.
Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using.
Studying mortality trends: The IMPACT CHD Policy Model
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
END Obesity Dr Gul Bano © S Nussey. What is obesity?
Integration of General Practice in Health services Doris Young Professor of General Practice.
Salford Primary Care Trust – your leader for health IN Salford Friday 12 th December 2008 Salford Primary Care Trust Strategic Plan Overview and Scrutiny.
Equal Treatment: Closing the gap Final results. Why we investigated ‘Far too many people…are dying in their 40s, 50s or even younger – far more than in.
Polypill x Aspirin Project Groups 3 and 4
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Lipid Lowering Drug Prescribing: ‘patchy’ guideline adherence despite multi-faceted interventions M.E. Cupples 1, Terry Bradley, Chris Hall 1 Dept General.
Tackling high blood pressure A case for CCG action Clinical Commissioning Group (CCG) slide deck – prepared 18/12/2015.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
Quality and Outcomes Framework The national Quality and Outcomes Framework (QOF) was introduced as part of the new General Medical Services (GMS) contract.
South West Public Health Observatory South West Regional Public Health Group Joint Strategic Needs Assessment Paul Brown Deputy Director South West Public.
Chapter 8 Adolescents, Young Adults, and Adults. Introduction Adolescents and young adults (10-24) Adolescence generally regarded as puberty to maturity.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Manchester’s Primary Care Led Prevention Programme Our Approach to a Radical Upgrade in Prevention and Population Health.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Health Inequalities. South Tyneside Life Expectancy Gap Life Expectancy – Males Local Value England England England average worst best
Management of Hypertension according to JNC 7
DR GHULAM NABI KAZI WHO Country Office Pakistan
Hypertension November 2016
Impact and costing of cardiovascular disease treatmentin Kwara State Health Insurance (KSHI) program. University of Ilorin Teaching Hospital (UITH) Amsterdam.
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
The Anglo Scandinavian Cardiac Outcomes Trial
Hypertension November 2016
Value Based Healthcare King’s Health Partners
The Heart Truth Delaware Background
Presentation transcript:

Using research to inform and change primary care Professor James Dunbar Greater Green Triangle UDRH

Males: 143,821 YLD 44% of total DALYs Cardiovascular 10% Cancer 8% Mental disorders 25% Chronic respiratory 10% Injuries 6% Musculo- skeletal 6% Diabetes 4% Other 15% Neurological 16% Females: 147,229 YLD 50% of total DALYs Cardiovascular 7%Cancer 7% Mental disorders 28% Neurological 18% Chronic respiratory 9% Injuries 3% Musculo- skeletal 10% Diabetes 4% Other 14% Years Lost Due to Disability (YLD) by sex and disease group, Victoria 1996

Areas with high and low DALY rates: Heart disease and diabetes high low

New Challenges for Better Health by 2010 Lifestyle and behaviours are key contributors to health and disease patterns

What is the research question?

What is the research method?

Levels of evidence l A meta-analysis, systematic review or RCTs l Bcase control or cohort studies l Cextrapolated from case control cohort studies l Dcase reports or expert opinion

EBM – the fallacy l General practice is holistic l Absence of evidence is not evidence of absence l Who pays? l Common sense and experts l Selective publication and publication bias l Lifestyle risk factors and population approaches

Systolic BP Risk % Prevalence % BP distribution, risk for coronary heart disease or stroke, and number of such morbid events in relation to blood pressure during 13.5 years’ follow-up of 855 men aged 50 at entry. Wilhelmsen BP distribution Morbid events Risk Morbid events n

MORTALITY CHANGES IN NORTH KARELIA IN 25 YEARS. ( AGE ADJUSTED, MEN) MORTALITY RATE IN CHANGE 1970 (PER ) IN 25 YEARS (%) TOTAL ALL CVD CORONARY CANCER LUNG Ca

RISK FACTOR CHANGES IN NORTH KARELIA 1972 AND 1992 AGE Male Female Smoking S-cholesterol Blood Pressure % mmol/l mmHg % mmol/l mmHg / / / /80

EBM – the fallacy l General practice is holistic l Absence of evidence is not evidence of absence l Common sense and experts l Selective publication and publication bias l Lifestyle risk factors and population level l Economic evidence, patients’ views and implementation

Evidence of Cost Effectiveness Patient Priorities & Satisfaction Evidence of Effective Service Delivery Evidence of Clinical Effectiveness Identify gaps in Research and Development Effective Healthcare

‘Evidence’ in CVD l Prava- or simvastatin l Other choice of drug l Dietary advice

Publishing quality improvement l Context l Outline of problem l Key measures of improvement l Process for gathering information l Analysis and interpretation l Strategy for change l Effects of change l Next steps

Change Not all change is improvement, but all improvement is change Real improvement comes from changing systems not changing within systems To make improvements we must be clear about what we are trying to accomplish, how we will know that change has led to improvement and what change we can make that will result in improvement The more specific the aim the more likely the improvement

Concentrate on meeting the needs of patients rather than the needs of organisations Measurement is the best for learning rather than for selection, reward or punishment Effective leaders challenge the status quo by insisting that the current system cannot remain and by offering clear ideas about superior alternatives

Fundamental Questions for Improvement l What are we trying to accomplish? l How will we know that a change is an improvement? l What changes can we make that will result in improvement?

Fundamental Questions for Improvement l What are we trying to accomplish? AIM

Fundamental Questions for Improvement l How will we know that a change is an improvement? MEASUREMENT All change does not lead to improvement, but all improvement requires change

Fundamental Questions for Improvement l What changes can we make that will result in an improvement? CHANGE IDEAS

Model for improvement l What are we trying to accomplish? l How will we know that a change is an improvement? l What changes can we make that will result in an improvement? Act Plan Study Do

Incremental improvement Time Performance low investment per project (small projects, but in large numbers) grass roots based; empowering (builds morale, customer satisfaction) needs reward and recognition system (reinforces improvement vision) 100% workforce participation

Secondary Prevention of Coronary Vascular Disease An Example of Improvement

CVD Project l Involved 105 GPs in 37 practices l All data shared unanonymously l Chosen as a model later applied to diabetes and hypertension l Became multidisciplinary

AIM: the original project Improve Secondary Prevention of CHD by developing and introducing a local guideline and auditing clinical management before and after introduction.

Lifestyle l Smoking Habits –19% (n=191) current smokers –Only 3 on Nicotine Replacement Therapy –On re-audit, rate down 1% (0-31%)

Lifestyle l 66% (n=702) received dietary advice at least once l On reaudit increased to 73%

Secondary prevention project: current components l Re-audit of practice activity December l Patient-held record card l Resources pack l Introduction and evaluation of Heartscore patient-interactive software l NURSE TRAINING

Cholesterol & Statins

Blood Pressure 31 % (n=302) diagnosed with Hypertension

Aspirin

Professions involved in training l dietician l diabetic physician, cardiologist, rehab. medicine specialist l general practitioners l health promotion staff l physiotherapist l pharmacist

Nurse training l Behaviour change skills (2 Days) l Smoking cessation l Diet and statin drugs to lower cholesterol l physical activity and angina management l diabetes/ hypertension l clinic management

Main outcomes l 10% reduction in admissions in first year

Peer Review l Facilitated inter-practice groups l collegiate approach l provided with good information l protected time